325 related articles for article (PubMed ID: 16875900)
21. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
22. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chaugai S; Meng WY; Ali Sepehry A
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
[TBL] [Abstract][Full Text] [Related]
23. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.
Ducharme A; Swedberg K; Pfeffer MA; Cohen-Solal A; Granger CB; Maggioni AP; Michelson EL; McMurray JJ; Olsson L; Rouleau JL; Young JB; Yusuf S
Am Heart J; 2006 May; 151(5):985-91. PubMed ID: 16644318
[TBL] [Abstract][Full Text] [Related]
24. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
25. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.
Madrid AH; Peng J; Zamora J; Marín I; Bernal E; Escobar C; Muños-Tinoco C; Rebollo JM; Moro C
Pacing Clin Electrophysiol; 2004 Oct; 27(10):1405-10. PubMed ID: 15511250
[TBL] [Abstract][Full Text] [Related]
26. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
Disertori M; Zeni P; Quintarelli S; Bonmassari R
G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
[TBL] [Abstract][Full Text] [Related]
27. The role of renin blockers in the prevention of diabetes.
Alkhenizan AH; Alswes MA
Saudi Med J; 2007 Jan; 28(1):91-5. PubMed ID: 17206297
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
L'Allier PL; Ducharme A; Keller PF; Yu H; Guertin MC; Tardif JC
J Am Coll Cardiol; 2004 Jul; 44(1):159-64. PubMed ID: 15234426
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials.
Han M; Zhang Y; Sun S; Wang Z; Wang J; Xie X; Gao M; Yin X; Hou Y
J Cardiovasc Pharmacol; 2013 Oct; 62(4):405-15. PubMed ID: 23921300
[TBL] [Abstract][Full Text] [Related]
30. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
Heusch G; Schulz R
Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
[TBL] [Abstract][Full Text] [Related]
31. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
32. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
Aksnes TA; Flaa A; Strand A; Kjeldsen SE
J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
[TBL] [Abstract][Full Text] [Related]
33. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
34. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
Salehian O; Healey J; Stambler B; Alnemer K; Almerri K; Grover J; Bata I; Mann J; Matthew J; Pogue J; Yusuf S; Dagenais G; Lonn E;
Am Heart J; 2007 Sep; 154(3):448-53. PubMed ID: 17719288
[TBL] [Abstract][Full Text] [Related]
35. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
[TBL] [Abstract][Full Text] [Related]
36. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
[TBL] [Abstract][Full Text] [Related]
37. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
[TBL] [Abstract][Full Text] [Related]
38. Does treatment with ACE inhibitors or angiotensin II receptor antagonists prevent atrial fibrillation after dual chamber pacemaker implantation?
Williams SG; Connelly DT; Jackson M; Bennett A; Albouaini K; Todd DM
Europace; 2005 Nov; 7(6):554-9. PubMed ID: 16216757
[TBL] [Abstract][Full Text] [Related]
39. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
40. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.
Durin O; Pedrinazzi C; Inama G
J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]